Related Experiment Videos
Type-specific opsonic antibodies in streptococcal pyoderma
Insights
Type-specific antibodies (TSA) develop in children infected with streptococcal pyoderma, particularly when strains colonize the throat. Pharyngeal carriage may be key for immunity to skin strains of Group A Streptococcus.
Area of Science:
- * Infectious Diseases
- * Immunology
- * Pediatrics
Background:
- * Streptococcal pyoderma is a common skin infection in children.
- * Understanding the immune response to Group A Streptococcus (GAS) is crucial for developing effective prevention and treatment strategies.
- * Previous studies have not fully elucidated the development of type-specific immunity following GAS skin infections.
Purpose of the Study:
- * To investigate the development of type-specific antibodies (TSA) in children with streptococcal pyoderma.
- * To explore the relationship between the site of GAS colonization (skin vs. throat) and TSA development.
- * To identify factors influencing the frequency of TSA development.
Main Methods:
- * Prospective study of black children in Project Headstart centers.
- * Sera collected and tested for opsonic antibodies against prevalent skin strains of GAS (M-types A and B).
- * GAS strains isolated from skin lesions and throat cultures; correlation with TSA development analyzed.
Main Results:
- * 36% of subjects had detectable antibodies to homologous serotypes.
- * TSA development was significantly higher in children with GAS isolated from throat cultures (72%) compared to skin lesions only (12%).
- * No correlation found between TSA development and antibodies to extracellular products or non-type-specific antigens.
Conclusions:
- * Type-specific immune responses occur following streptococcal pyoderma infections.
- * The frequency of TSA development is influenced by the infecting GAS strain and colonization site.
- * Pharyngeal carriage of GAS may be an important mechanism for developing acquired immunity to skin strains.
Abstract:
Prospective studies of streptococcal pyoderma were carried out among black children enrolled in Project Headstart centers in Holmes County, Miss. Sera collected from 28 of these children in early October were tested for opsonic antibodies to one of two prevalent skin strains of group A streptococci isolated from them on one or more occasions over the preceding 3 months. The two streptococcal strains (A and B) belong to M-types previously unrecognized. Ten subjects (36%) had antibody to their homologous serotypes detectable by the indirect bactericidal test: this included 6 of 10 subjects infected with strain B but only 4 of 18 infected with strain A (P < 0.05). Of 17 children who had strains A or B isolated from skin lesions only, 12% developed type-specific antibodies (TSA) against the infecting serotype. In contrast, 11 subjects had these strains isolated from throat cultures (either with or without associated pyoderma), and 72% had detectable TSA (P < 0.01). There was no demonstrable relationship between the development of antibodies to streptococcal extracellular products or to non-type-specific cellular antigens and the development of TSA. These results demonstrate that type-specific immune responses do occur following infection with pyoderma streptococci. The frequency with which such antibodies develop is variable and appears related to a number of factors, including the immunologic properties of the infecting strain and the site of bacterial colonization. Pharyngeal carriage may represent an important mechanism for development of acquired immunity to skin strains of group A streptococci.